Search Results - Karl Staser

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Mast cells and the neurofibroma microenvironment

    Mast cells and the neurofibroma microenvironment by Karl Staser, Feng‐Chun Yang, D. Wade Clapp

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression

    Pathogenesis of Plexiform Neurofibroma: Tumor-Stromal/Hematopoietic Interactions in Tumor Progression by Karl Staser, Feng‐Chun Yang, D. Wade Clapp

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia

    The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia by Mark A. Schroeder, Jaebok Choi, Karl Staser, John F. DiPersio

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood

    OMIP‐042: 21‐color flow cytometry to comprehensively immunophenotype major lymphocyte and myeloid subsets in human peripheral blood by Karl Staser, William Eades, Jaebok Choi, Darja Karpova, John F. DiPersio

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response

    Mogamulizumab-Associated Cutaneous Granulomatous Drug Eruption Mimicking Mycosis Fungoides but Possibly Indicating Durable Clinical Response by Lu Chen, Kenneth R. Carson, Karl Staser, Neha Mehta–Shah, András Schaffer, Ilana S. Rosman, Amy Musiek

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity

    Erk1 Positively Regulates Osteoclast Differentiation and Bone Resorptive Activity by Yongzheng He, Karl Staser, Steven D. Rhodes, Yaling Liu, Xiaohua Wu, Su-Jung Park, Jin Yuan, Xianlin Yang, Xiaohong Li, Li Jiang, Shi Chen, Feng‐Chun Yang

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease

    Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease by Jaebok Choi, Matthew Cooper, Karl Staser, Kidist Ashami, Kiran Vij, Bing Wang, Lynne Marsala, Jessica Niswonger, Julie Ritchey, Bader Alahmari, Samuel Achilefu, Ikuo Tsunoda, Mark A. Schroeder, John F. DiPersio

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity

    A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity by Miriam Kim, Reyka G. Jayasinghe, Jessica M. Devenport, Julie Ritchey, Michael P. Rettig, Julie O’Neal, Karl Staser, Krista Kennerly, Alun Carter, Feng Gao, Byung Ha Lee, Matthew Cooper, John F. DiPersio

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

    An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies by Jingyu Xiang, Jessica M. Devenport, Alun Carter, Karl Staser, Miriam Kim, Julie O’ Neal, Julie Ritchey, Michael P. Rettig, Feng Gao, Garrett R. Rettig, Rolf Turk, Byung Ha Lee, Matthew Cooper, John F. DiPersio

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model

    Hyperactive Transforming Growth Factor-β1 Signaling Potentiates Skeletal Defects in a Neurofibromatosis Type 1 Mouse Model by Steven D. Rhodes, Xiaohua Wu, Yongzheng He, Shi Chen, Hao Yang, Karl Staser, Jiapeng Wang, Ping Zhang, Chang Jiang, Hiroki Yokota, Ruizhi Dong, Xianghong Peng, Xianlin Yang, Sreemala Murthy, Mohamad Azhar, Khalid S. Mohammad, Mingjiang Xu, Theresa A. Guise, Feng‐Chun Yang

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease

    A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease by Mark A. Schroeder, H. Jean Khoury, Madan Jagasia, Haris Ali, Gary J. Schiller, Karl Staser, Jaebok Choi, Leah Gehrs, Michael Arbushites, Ying Yan, Peter Langmuir, Nithya Srinivas, Michael A. Pratta, Miguel‐Angel Perales, Yi‐Bin Chen, Gabrielle Meyers, John F. DiPersio

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

    An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies by Matthew Cooper, Jaebok Choi, Karl Staser, Julie Ritchey, Jessica M. Devenport, Kayla Eckardt, Michael P. Rettig, Bing Wang, Linda Eissenberg, Armin Ghobadi, Leah Gehrs, Julie L. Prior, Samuel Achilefu, Christopher A. Miller, Catrina C. Fronick, Julie O’Neal, Feng Gao, David M. Weinstock, Alejandro Gutiérrez, Robert S. Fulton, John F. DiPersio

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation

    A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation by Jeffrey R. Gehlhausen, Su-Jung Park, Ann E. Hickox, Matthew Shew, Karl Staser, Steven D. Rhodes, K.M.J. Menon, Jacquelyn D. Lajiness, Muithi Mwanthi, Xianlin Yang, Jin Yuan, Paul R. Territo, Gary D. Hutchins, Grzegorz Nalepa, Feng‐Chun Yang, Simon J. Conway, Michael G. Heinz, Anat Stemmer‐Rachamimov, Charles W. Yates, D. Wade Clapp

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Identification of molecular compartments and genetic circuitry in the developing mammalian kidney

    Identification of molecular compartments and genetic circuitry in the developing mammalian kidney by Jing Yu, M. Todd Valerius, Mary Duah, Karl Staser, Jennifer K. Hansard, Jinjin Guo, Jill A. McMahon, Joe E Vaughan, Diane Faria, Kylie Georgas, Bree Rumballe, Qun Ren, A. Michaela Krautzberger, Jan Philipp Junker, Rathi D. Thiagarajan, Philip Machanick, Paul A. Gray, Alexander van Oudenaarden, David H. Rowitch, Charles D. Stiles, Qiufu Ma, Sean M. Grimmond, Timothy L. Bailey, Melissa H. Little, Andrew P. McMahon

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial

    Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial by Kent A. Robertson, Grzegorz Nalepa, Feng‐Chun Yang, Daniel C. Bowers, Chang Yueh Ho, Gary D. Hutchins, James M. Croop, Terry A. Vik, Scott C. Denne, Luis F. Parada, Cynthia M. Hingtgen, Laurence E. Walsh, Menggang Yu, Kamnesh R. Pradhan, Mary Edwards‐Brown, Mervyn D. Cohen, James Fletcher, Jeffrey B. Travers, Karl Staser, Melissa W. Lee, Marcie R. Sherman, Cynthia J. Davis, Lucy Miller, David A. Ingram, D. Wade Clapp

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: